A novel pan-PI3K inhibitor KTC1101 synergizes with anti-PD-1 therapy by targeting tumor suppression and immune activation
Article in Molecular Cancer (March 2024)
The most recent citing publications are shown below. View all 46 publications that cite this research output on Dimensions.
Article in Molecular Cancer (March 2024)
Article in Molecular Carcinogenesis (February 2024)
Article in Hematology (April 2023)